Essential surgical skills for a gynecologic oncologist

Arora, Vivek; Somashekhar, S. P.

doi:10.1002/ijgo.12619

Cited by 12 publications

(6 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various quality improvement systems to optimize clinical outcome and patient safety have been adapted to health care system, and measures of “quality” can be quantified by using different indicators. 3 4 5 Traditionally, quality of care has been evaluated from 3 different levels: structure, process, and outcome. 2 6 Structural indicators of quality include environmental features of care, such as trained personnel, hospital facilities, and equipment.…”

Section: Discussionmentioning

confidence: 99%

“…It has been clear, that the quality and extent of surgery influence the perioperative complications, overall morbidity, local tumor control and eventually, recurrence and survival. 2 3 4 In other gynecologic cancers including ovarian cancer, it has been proved that the clinical outcome was superior when treated in quality controlled, specialized institution, by specialists. 3 5 This is possibly due to appropriate preoperative judgment, accurate diagnosis, optimal surgical technique as well as effective postoperative care.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of Quality Control Program in Surgical Management of Early Cervical Cancer

Shim

Kim

et al. 2021

J Korean Med Sci

View full text Add to dashboard Cite

Background Regular assessments of clinical performance in gynecologic cancer surgery is important for the safety of patients. We evaluated the effects of quality control (QC) program on the treatment pattern and clinical outcomes of early cervical cancer. Methods Medical records of cervical cancer patients who received operation in our institution from January 2007 to December 2018 were retrospectively reviewed. Cases were divided into 2 groups, before and after the initiation of QC program, group 1 (2007–2013) and group 2 (2014–2018), based on the operation date. Two groups were compared in clinicopathologic variables, surgical methods, operative details, adjuvant treatments, recurrence and survival. Results A total of 305 cervical cancer patients were included in the analysis, 210 in group 1 and 95 in group 2. In group 2, minimally invasive surgery (MIS) was more frequently performed (60.0% vs. 76.8%, P = 0.004), especially in earlier stages (stage IA, 72.6% vs. 100.0%; stage IB, 52.2% vs. 69.5%). However, the median tumor size treated by MIS was decreased in stage IB (20 mm vs. 17 mm, P = 0.015). Frequency of adjuvant treatment was also reduced in stage IB (56.5% vs. 37.3%, P = 0.016). Recurrence within 3 years, 3-year disease free survival and overall survival did not show significant difference; however, 3-year recurrence after MIS was significantly reduced in stage IB. Conclusion QC program enforced stricter patient selection criteria for MIS and positively affected clinical outcomes in cervical cancer patients who underwent surgery. Systemic monitoring should be considered for patient safety.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Effect of Quality Control Program in Surgical Management of Early Cervical Cancer

Shim

Kim

et al. 2021

J Korean Med Sci

View full text Add to dashboard Cite

show abstract

“…Surgical intervention is often the first step in diagnosis, staging and treatment in gynaecological cancer 14 . The increasing burden of cancer in India provides opportunities for GO training.…”

Section: Training In India: Opportunities For Next-generation Gynaeco...mentioning

confidence: 99%

“…The options can be in the form of a two-year fellowship or super-speciality with a DM degree in gynaecologic oncology and brachytherapy 35 . A similar programme is now established by starting a MCh in gynaecologic oncology 14 .…”

Section: Challenges In the Trainingmentioning

confidence: 99%

Training for next-generation gynaecologic surgical & radiation oncologists – opportunities & challenges

Ram

Thomas

Sathyamurthy

et al. 2021

Indian Journal of Medical Research

View full text Add to dashboard Cite

The global increase in cancer burden is a challenge for countries with scarce resources. Amongst all the malignancies, gynaecological cancer still continues to have a high incidence and prevalence leading to significant morbidity and mortality. While a multipronged strategy of decreasing the gynaecological cancer burden is a global priority, one of the key strategies to decrease the morbidity and mortality is to train gynaecological oncology specialists. Most of the developed nations have an established gynaecologic oncology training programme in the form of a well-designed curriculum and skill training. However, in developing countries where the actual disease burden of these cancers is highest, such focused training programmes have only started emerging and evolving over the past two decades. While it is a positive step to initiate such training programmes in a country like India, there are still gaps in the uniformity of curriculum and training. Also, exposure to modern practices in gynaecologic oncology surgery, chemotherapy and technology in radiation oncology, especially brachytherapy, is still insufficient in many centres. This review discusses some of the challenges and opportunities in the still evolving programmes for training gynaecologic oncologists in India.

show abstract

“…Contemporary data suggest that the amount of postoperative residual tumor is the most significant factor for the survival of patients with advanced ovarian cancer (1,2). Ovarian cancer frequently invades the small and large intestines, making bowel resection a crucial part of cytoreductive surgery (1,(3)(4)(5)(6). As tumors invade multifocal areas of the bowel serosa and mesentery without clear boundaries, gynecologic oncology surgeons often need to make intraoperative decisions regarding the extent of bowel resection, taking into consideration the preservation of bowel function and technical feasibility.…”

Section: Introductionmentioning

confidence: 99%

Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer

Son¹,

Chang²

2021

Gland Surg

View full text Add to dashboard Cite

Ovarian cancer is known as the second most common cause of death among gynecologic cancers.Survival outcome has been reported to be significantly associated with the efforts to minimize residual disease after cytoreductive surgery. As ovarian cancer often invades the small and large bowel without boundary, bowel surgery has been a crucial part of the cytoreductive surgery to achieve complete tumor removal. The scope of surgical resections has progressively expanded to include small and large bowel resections, making advanced surgical skills essential for gynecologic oncologists. In this review, we discuss the extra-pelvic bowel resection in cytoreductive surgery, with a focus on the regional anatomy and surgical techniques.

show abstract

Essential surgical skills for a gynecologic oncologist

Cited by 12 publications

References 64 publications

Effect of Quality Control Program in Surgical Management of Early Cervical Cancer

Effect of Quality Control Program in Surgical Management of Early Cervical Cancer

Training for next-generation gynaecologic surgical & radiation oncologists – opportunities & challenges

Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer

Contact Info

Product

Resources

About